Unity Biotechnology Inc (NAS:UBX)
$ 1.42 0.01 (0.71%) Market Cap: 23.92 Mil Enterprise Value: 11.43 Mil PE Ratio: 0 PB Ratio: 1.21 GF Score: 36/100

UNITY Biotechnology Inc Corporate Call Transcript

Jul 06, 2021 / 12:00PM GMT
Release Date Price: $44.1 (-1.34%)
Operator

Good day, and thank you for standing by. Welcome to the UNITY Biotechnology's conference call. (Operator Instructions) Please be advised that today's conference may be recorded.

I would now like to hand the conference over to your speaker today, Lynne Sullivan, Chief Financial Officer. Please go ahead.

Lynne Marie Sullivan
Unity Biotechnology, Inc. - CFO & Head of Corporate Development

Good morning, everyone. Thank you for joining UNITY Biotechnology's conference call this morning to discuss the Phase I results from our UBX1325 program. With me on today's call is Anirvan Ghosh, the CEO of UNITY Biotechnology; Jamie Dananberg, the Chief Medical Officer of UNITY Biotechnology; and myself, Lynne Sullivan, the Chief Financial Officer.

Before turning the call over to Anirvan, I'd like to remind you that during today's call, we will be making some forward-looking statements which are subject to the risks and uncertainties, including those described in our latest 10-Q filed with the SEC. Actual results may differ materially from today's forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot